The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial

Autor: Job F. H. Eijsink, Paul A. F. Geerts, Karin Kamminga, Mireille A. Edens, Cornelis Boersma, Maarten J. Postma, Jan Gerard Maring, Peter G. J. ter Horst

Publikováno v: PLoS ONE, Vol 19, Iss 8 (2024)

Externí odkaz: https://doaj.org/article/12a80e79b6af4df98e23833878393ca1

Developing a patient portal for haematology patients requires involvement of all stakeholders and a customised design, tailored to the individual needs

Autor: Paul A. F. Geerts, Trudy van der Weijden, Pien G. M. Loeffen, Lise E. F. Janssen, Celine Almekinders, Tobias A. Wienhold, Gerard M. J. Bos

Publikováno v: BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-10 (2019)

Abstract Background Electronic patient portals are increasingly being implemented, also in (haemato) oncology. However, portal usage is low and depends on user and provider engagement. We explored wishes, expectations and thoughts of patients with a

Externí odkaz: https://doaj.org/article/3cfa8226ada049f7b00c8ae891b6191c

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study

Autor: Inge Ludwig, Ellen van der Spek, Paul A F Geerts, Pieter Sonneveld, Margriet Oosterveld, Yavuz M. Bilgin, Savita Soechit, Niels W.C.J. van de Donk, Noortje Thielen, Nicole C H P de Graauw, Mark-David Levin, Gert Jan Timmers, Inger S. Nijhof, Kazem Nasserinejad, Alain Kentos, Marjolein van der Klift, Claudia A.M. Stege, Saskia K. Klein, Esther G.M. De Waal, Matthijs H Silbermann, Maaike Sohne, Marie-Christiane Vekemans, Sonja Zweegman, Roel J.W. van Kampen, Nazik Durdu-Rayman

Publikováno v: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143

PURPOSE Frail patients with newly diagnosed multiple myeloma have an inferior outcome, mainly because of a high discontinuation rate due to toxicity. We designed a phase II trial specifically for frail patients, evaluating the efficacy and tolerabili

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd16999f1d8f8fc2bbefd1520cedee3
https://hdl.handle.net/2078.1/261917